跳至主要内容
临床试验/ACTRN12624000356561
ACTRN12624000356561尚未招募Unknown

Investigating the immunomodulatory and clinical effects of fermentable fiber dietary intervention to reduce symptoms of post-acute sequelae of SARS-CoV-2 infection in adults

Monash University0 个研究点目标入组 40 人开始时间: 2024年3月28日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults (18 years and over)
  • Diagnosis of Long COVID, defined as symptoms persisting for more than 3 months after being infected with SARS-CoV-2
  • Experiencing symptoms of Brain fog and fatigue

排除标准

  • Currently taking immunosuppressive medications
  • Have taken antibiotics in the past 2 months
  • Existing history of functional gut symptoms indicative of poor tolerance to fermentable fibres
  • Currently adhere to a vegan or vegetarian diet
  • Pregnant or planning pregnancy
  • Unable to speak or read English

研究者

相似试验